Skip to content

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

Home
Pharma applications
Non-pharma applications
CD derivatives
Events
E-ducation

January 15, 2020 Events / Non-pharma applications / Pharma applications

ICS2020, abstract submission deadline extended

Posted by evafenyvesi

The bew deadline for abstract submission: FEBRUARY 4^th 2020, 23:59 CET.

http://www.ismn.cnr.it/ics2020/abstract_submission.html

Share this:

LinkedIn
Facebook
Twitter
WhatsApp
Email

Like this:

Like Loading...

conference

Post navigation

Cyclodextrin polymer of reduced ototoxicity improves atherosclerosis therapy

6th NANO Boston Conference

Leave a ReplyCancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Search for:

Recent Posts

Phase III Results of Adamgammadex
Comparison of cholesterol complexation with β-cyclodextrin derivatives: A combined theoretical and experimental study
Molecular Mind Games: The Medicinal Action of Cyclodextrins in Neurodegenerative Diseases
Geographical variation of gut microflora shows diversity in catabolizing alpha-cyclodextrin
Low melting mixtures: Neoteric green solvents for flavor formulation

Tags

alpha-CD Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food Gilead HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

LinkedIn
Twitter
Facebook

Categories

Agriculture (18)
Analysis (40)
CD as API (236)
CD derivatives (290)
Cosmetics and toilettry (23)
Diagnosis (3)
Drug delivery (513)
E-ducation (59)
Environmental (85)
Events (175)
Food (147)
Gene delivery (12)
In Hungarian (4)
Life sciences (26)
Non-pharma applications (260)
Other industrial use (74)
Pharma applications (804)
Supramolecular systems (30)
Uncategorized (64)

Top Posts

Australian company pioneering Cavadextrin for regression of atherosclerosis
Phase III Results of Adamgammadex
Wasabi's bioactive component 6-MSITC formulated with alfa-cyclodextrin improved memory proven in clinical trial.
Comparison of Selective Relaxant Binding Agent Adamgammadex Sodium with Sugammadex for Reversing Rocuronium-Induced Deep Neuromuscular Block
Lanosterol eye drops for cataract treatment
16th Annual World Cancer Congress
CicloTech®, a new platform to improve trans-ungual drug release
Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
Symposium of Drug Delivery Systems
The Effect of Cyclodextrins in Cholesterol and Ganglioside Depletion in Rat Brain Synaptosomes

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Email Address

Join 570 other subscribers

%d